Abstract
Background
Early recognition and prompt intramuscular epinephrine administration are critical for the treatment of anaphylaxis. The special emergency medical service team (SEMST) is a reorganization plan that incorporates first-level emergency medical technicians (EMTs) and nurses from Korea to give the authority to administer epinephrine. This study evaluates the experience of SEMST and aims to investigate further needs in the pre-hospital management of anaphylaxis.
Methods
An online survey of 29 questions on the Gangwon-do 119 EMST was conducted. IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) and R ver.4.0.3. were used for statistical analysis.
Results
A total of 428 (44.6%) participants responded to the questionnaire, and 55.6% (238/428) experienced anaphylaxis. The common presumed cause was insect sting/animal bites at 84.5% (201/238), followed by food (7.6%, 18/238), and drugs (6.3%, 15/238). The frequency of occurrence was highest for tourist attractions (58.6%, 167/285), followed by homes (31.9%, 91/285) and workplace (3.5%, 10/285). Among 136 medical personnel (31.8%) who were currently active or had been active as the SEMST, 95 (70.0%) experienced anaphylaxis, and 58 (61.1%) used epinephrine, which was significantly lower in the non-SEMST group (n = 36, 25.2%). The biggest difficulty in pre-hospital treatment was the limitation of drug administration authority (23.4%, 22/95). The lack of experience and tricky treatment are the chief difficulties in pediatric anaphylaxis. The percentage of correct answers regarding anaphylaxis awareness was significantly higher in the educated (n = 374) than in the non-educated group (n = 54), both for diagnosis (24.9% vs. 11.1%) and treatment (73.5% vs. 37.0%).
Graphical Abstract
Anaphylaxis is a life-threatening medical emergency, and its prevalence is on the rise worldwide, highlighting the importance of treatment, prevention, and management in communities.123 Food, drug, insect, and bee venom are the typical causes of anaphylaxis, but the incidence of these common causes varies between studies. In children, anaphylaxis is most commonly caused by food intake.456 Patients are given a thorough education about avoiding causative food allergens and contamination risk to prevent anaphylaxis.78 However, there are cases of anaphylaxis caused by inevitable exposure to the allergen through meals from childcare facilities and restaurants.9 In adults, drug and bee venom are common causes of anaphylaxis.4 Pre-hospital treatment is crucial for these cases of anaphylaxis, as anaphylaxis caused by drug allergy often involves a drop in blood pressure and is often fatal, and exposure to bee venom is during outdoor activities.10
Prompt epinephrine intramuscular injection is the most crucial aspect in the treatment of anaphylaxis. Anaphylaxis is marked by systemic skin, respiratory, gastrointestinal, cardiovascular, and neurological symptoms, as the causative antigen activates mast cells, including histamine, leading to a quick release of mediators that cause systemic vasodilation and mucosal swelling. Epinephrine, which can quickly resolve all of these symptoms, is the treatment of choice.7811 Therefore, for early self-treatment, it is important to prescribe one or more epinephrine autoinjectors (EAIs) for patients at potential risk.71213
In South Korea, the 119 emergency medical service team (EMST) is responsible for basic life support and patient transport.14 Healthcare providers, including nurses, and the first- and second-level emergency medical technicians (EMTs) are qualified to become 119 EMST. However, as per Article 33 of the Enforcement Rule of the Emergency Medical Service Act,15 epinephrine intramuscular injection can be given by 119 EMST with the assistance of physicians (e.g., via video calls). However, it has not been authorized for the treatment of anaphylaxis, even in 2021. There have been continuous voices to, at least, partially expand the scope of practice for 119 EMST to include epinephrine intramuscular injection in anaphylaxis pre-hospital management,1617 and the National Fire Agency Korea launched the pilot project of special EMST (SEMST) in July 2019 and expanded the project nationwide in December of the same year. An SEMST comprises the first- and second- level EMTs and nurses. Among them, some first-level EMTs and nurses who completed special education are authorized to administer intramuscular epinephrine for anaphylaxis with assistance of physicians via a video call. Improvements in anaphylaxis pre-hospital management since the launch of this pilot project are yet to be evaluated.
The need for pre-hospital anaphylaxis management has rarely been studied. In this study, we attempted to examine whether establishing 119 SEMST as a pilot project and authorizing them to administer epinephrine indeed improved anaphylaxis treatment and to identify further needs in the field. Further, we administered an education program about anaphylaxis to evaluate the effectiveness in Gangwon-do 119 EMST, which serves in one of the largest rural areas in South Korea. We evaluated the effectiveness of the education through a survey in order to present valuable data for enhancing the quality of pre-hospital anaphylaxis management and community health care.
An online questionnaire survey was administered to 119 EMST in Gangwon-do from November 2020 to December 2020. The online survey was developed by allergists, and data were collected via Google Forms on a professional account. The online poll was reached via a hyperlink. The collected data were secured on protected computers with limited access to the members of the Gangwon-do Atopy · Asthma Education Information Center. Participation was anonymous and voluntary. Questions in different categories were asked. The first category was about participants' characteristics, including sex, age, and qualifications; first-level EMT, second-level EMT, and medical personnel (e.g., nurses), work experience, career as SEMST: current, former, never been, experience of anaphylaxis and pediatric anaphylaxis. The second category consisted of questions about participants' knowledge of the diagnosis and treatment of anaphylaxis. The third category was about participants' experiences with anaphylaxis, primarily asking about the cause, place, treatment, including epinephrine injection and patient's possession of EAI. The fourth category consisted of an open question about the difficulties in pre-hospital anaphylaxis management. The total number of questions was 29, with one open-ended, seven close-ended-multiple-choice, and all other close-ended-single-choice questions.
All variables were categorical, and therefore, number (%) was presented. For variables with multiple responses, all responses were summed and presented as percentages. Yates' continuity correction was used to adjust for the differences in the probability value by analyzing noncontinuous categorical data with a χ2 test. Statistical analyses were performed using the IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) and R ver. 4.0.3, and statistical significance was set at P < 0.05.
Of the 960 questionnaires, 428 (44.6%) were retrieved. The participants consisted of 153 first-level EMTs (35.7%), 209 second-level EMTs (48.8%), and 66 medical personnel (15.4%). A total of 251 (58.6%) participants had field experience of three years or more. Ninety-nine (23.1%) currently served in the SEMST, while 37 (8.6%) had served in the SEMST in the past. Among all responders, 55.6% (238/428) had experienced anaphylaxis pre-hospital management, 12.6% of whom (30/238) were dispatched more than five times a year. Only 3.8% (9/238) had experience with pediatric (≤ 12 years) anaphylaxis pre-hospital management (Table 1).
Participants with experience in anaphylaxis pre-hospital management were asked about the suspected cause of anaphylaxis, and 84.5% (201/238) chose insect sting/animal bites, followed by food (7.6%, 18/238) and drug (6.3%, 15/238). Common locations of occurrence (multiple responses, n = 285) included tourist attraction (outdoors) (58.6%, 167/285), home (31.9%, 91/285), workplace (3.5%, 10/285), restaurant (3.2%, 9/285), and school (2.8%, 8/285). Common types of pre-hospital management, also a multiple-response question (n = 623), included oxygen supply (28.7%, 179/623), blood pressure measurement (28.3%, 176/623), electrocardiogram (ECG) monitoring (21.2%, 132/623), and drug administration, including epinephrine (20.4%, 127/623). Ninety-four participants (39.5%) had experienced epinephrine administration. In the question asking whether more than half of the patients encountered during dispatch were considered to have recurrent episodes with prior anaphylaxis history, 130 (54.6%) said yes. However, only four (1.7%) participants answered yes to whether more than half of the patients possessed an EAI. Forty (17.6%) participants encountered a patient in possession of an EAI, and 36 (90.0%) of them stated that less than half of these patients used the device on their own (Table 2). Regarding the frequency of epinephrine administration among 238 participants with experience in anaphylaxis pre-hospital management, 61.1% people in the past or current SEMST group (SEMST+, 58/95) and 25.2% in the non-SEMST group (SEMST−, 36/143) had administered epinephrine, showing a significantly higher percentage in the SEMST+ group (Fig. 1).
A total of 374 (87.4%) participants completed anaphylaxis education programs offered at the Gangwon-do Atopy · Asthma Education Information Center, and 339 (91.6%) of these had completed the education in the past two years. Correct response rates for the question about diagnosis were significantly higher in the educated (24.9%, 93/374) than in the non-educated group (11.1%, 6/54) (Fig. 2A). Answer rates for the question about treatment were also significantly higher (two times) in the educated group (73.5%, 275/374) than in the non-educated group (37.0%, 20/54) (Fig. 2B).
Difficulties in treating patients with anaphylaxis were surveyed using an open-ended question, and 94 (22.0%) answered the question. The most common challenge was authority limitations on practice, as mentioned by 22 participants (23.4%). Other difficulties included lack of experience (n = 18, 19.1%), rapid worsening of symptoms (n = 12, 12.8%), and disease recognition (n = 8, 8.5%) (Fig. 3A). For the multiple-response question about difficulties in treating children with anaphylaxis, 75.9% (368/485) chose lack of experience, followed by management (12.0%, 58/485) and disease recognition (6.8%, 33/485) (Fig. 3B). For the multiple-response question about the challenges of proper administration of epinephrine, 72.9% (342/469) chose lack of experience, followed by authority limitations on practice (13.9%, 65/469) and disease recognition (5.1%, 24/469) (Fig. 3C).
Prompt epinephrine intramuscular injection is the treatment of choice for anaphylaxis, and epinephrine administration during pre-hospital management not only significantly lowers disease severity but also reduces mortality. As a result, delayed administration of epinephrine in anaphylaxis is a major risk factor for mortality.1819 The time of epinephrine administration based on arrival at the emergency department (ED) for anaphylaxis in rural areas in South Korea is 32 minutes, which is longer than 21 minutes in urban areas.20 This means that pre-hospital management, including epinephrine administration, is particularly necessary. The results of this study showed that SEMST had significantly more experience (more than two-fold) with epinephrine administration than non-SEMST rescue teams, suggesting that the pilot project of SEMST for anaphylaxis, which emphasizes enhanced authority, is effective in improving pre-hospital management. Therefore, it should be expanded and established in South Korea. A notable 25.2% of the participants not in the SEMST also specified to have administered epinephrine, suggesting that its administration by unauthorized providers is inevitably done with physicians' assistance. This rate ranged from 8.3% to 33.3% in previous studies,2122 and the higher rate observed in this study is presumably attributable to the features of Gangwon-do, characterized by large mountainous areas and a long time from dispatch to arrival at the ED. Still, many participants specified experience and limited authority as the major difficulties with pre-hospital management, and treatments such as oxygen supply, blood pressure measurement, and ECG monitoring were performed prior to medication administration in pre-hospital anaphylaxis management, raising concerns for undertreatment risk. Enhancing authority is crucial for proper treatment, and this need was especially high in rural areas. This highlights the need to consider expanding authority in rescue teams.
The side effects of intramuscular epinephrine injection include paleness, tremor, palpitations, and headache, but most are temporary.2324 However, administering a high dose may lead to emergencies, such as ventricular tachycardia and elevation of blood pressure, and incorrect administration may also lead to tissue necrosis.25 Therefore, lack of experience may be a barrier to epinephrine administration despite continuous education. Thus, it is necessary to increase the stability of administration by equipping teams with EAI or prefilled syringes by body weight and providing continuous and periodic education, along with simulation-based programs that resemble real-life situations.
According to Korean study data, food is the major cause of anaphylaxis, and drugs are also common causes.426 However, in this study, 84.5% of the participants chose insect sting/animal bites as the cause of anaphylaxis, with only 7.6% choosing food as the cause. In addition to recall bias, the difference in these data may be attributable to the fact that past studies were chart reviews or registry analyses of patients who presented to the ED using their own vehicles or other routes and hospitalized, while our study was a survey of anaphylaxis cases reported to the 119 EMST. However, we believe that the major reason for this gap is pertinent to the features of Gangwon-do, the region of this study. Gangwon-do is a rural area located on the eastern side of the Korean peninsula, featuring large mountainous areas, the lowest population density, and high dependence on tourism and agricultural industries.27 Regarding commonplaces of occurrence, 58.6% chose tourist attraction sites, which is different from the results of a previous Korean study25 and a European study,28 where the most common place of occurrence was home. Cases of anaphylaxis in rural areas differ from those in urban areas, and one such difference is high prevalence.29 The fact that more than half of our survey had experience with pre-hospital anaphylaxis management supports this result. Moreover, the common causes and places of anaphylaxis occurrence differed from those reported in previous studies, suggesting the need to reflect regional features in the general care of rural area anaphylaxis. However, the format of the questionnaire that requires answers to its categorized questions to be made between Yes or No made it unable to distinguish between insect stings and animal bites. This caused the study to be limited in its inability to identify the specific problematic antigen and characteristics of symptoms, which warrants future research.
About 87.4% of the participants completed an education program about anaphylaxis, which is a marked improvement from the 119 EMST anaphylaxis educated rate (16.0%) in the Gangwon-do Atopy · Asthma Education Information Center surveyed and reported in 2017.30 In addition, disease knowledge also significantly differed according to prior education, with a nearly two-fold higher correct answer rate for the method of epinephrine administration among educated EMTs. In the 2017 disease knowledge evaluation, there were issues regarding the low correct answer rate for items pertaining to disease recognition and treatment administration, even among those who had been educated, which seems to be an outcome of ameliorating the education project to include theory and practical training led by allergy specialists. This has contributed to the improved awareness observed in this study. However, participants still reported difficulties in disease recognition and treatment for pediatric anaphylaxis cases due to lack of experience or vague or caregiver-described symptoms, which should be resolved through the use of simulation training. In addition, the continuously low rate of correct answers regarding disease awareness demonstrates that by assigning SEMST the responsibility to determine whether EAI administration is required may hinder appropriate treatment. Thus, it is advisable to expand their authority to enable prompt administration on treating the disease, while systemizing physicians' assistance such as video calls.
The fact that many patients did not have an EAI despite having recurrent episodes of anaphylaxis and the low self-use rate among those who had one is an issue to be addressed by physicians. Physicians should prescribe EAI for anaphylaxis prevention and strive to eliminate the barriers to self-use by utilizing different education tools.
One limitation of this study is that it is a survey relying on participant recall and that the response rate was low. In addition, the questionnaire used in this study has never been previously used; therefore, its validity and reliability have not been established. Nevertheless, this study is significant as the first effectiveness evaluation of the pilot project of SEMST for anaphylaxis, assessing the entire rescue team in the rural region of study using the same tool, and enrolling a large sample. Moreover, our findings serve as grounds for supporting the effectiveness of the SEMST project, which has begun the restructuring of authority.
In conclusion, proper administration of epinephrine is particularly important for pre-hospital anaphylaxis management in rural areas. Expanding SEMST with the authority to administer epinephrine and conducting periodic education using virtual experiences is necessary. Implementing prefilled syringes by body weight and utilizing video-based assistance materials to further expand SEMST would enable safer and more appropriate epinephrine administration in anaphylaxis pre-hospital management.
ACKNOWLEDGMENT
This research was supported by funds from the Atopy · Asthma Education Information Korea Disease Control and Prevention Agency. We would like to express our gratitude to the Korea Disease Control and Prevention Agency, Gangwon Provincial Government, Gangwon Fire Headquarters, and Gangwon-do Atopic Asthma Education Information Center for their cooperation. We would also like to thank the all the members of emergency medical service team in Gangwon Fire Headquarters for their participation.
Notes
Author Contributions:
Conceptualization: Kwon JW, Lee J.
Data curation: Lee H, Jeong YW, Lee C, Lee J.
Formal analysis: Lee H, Kwon JW, Lee J.
Funding acquisition: Kwon JW.
Investigation: Lee H, Kwon JW, Jeong YW.
Methodology: Lee J, Lee H, Jeong YW.
Project administration: Kwon JW.
Resources: Kwon JW, Lee H, Jeong YW.
Software: Jeong YW.
Supervision: Lee J.
Validation: Lee H, Lee J.
Visualization: Jeong YW, Lee H.
Writing - original draft: Lee H.
Writing - review & editing: Lee H, Lee C, Kwon JW, Lee J.
References
1. Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF, et al. World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013; 162(3):193–204. PMID: 24008815.
2. Yang MS, Kim JY, Kim BK, Park HW, Cho SH, Min KU, et al. True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database. Medicine (Baltimore). 2017; 96(5):e5750. PMID: 28151851.
3. Yu JE, Lin RY. The epidemiology of anaphylaxis. Clin Rev Allergy Immunol. 2018; 54(3):366–374. PMID: 26357949.
4. Jeong K, Ye YM, Kim SH, Kim KW, Kim JH, Kwon JW, et al. A multicenter anaphylaxis registry in Korea: clinical characteristics and acute treatment details from infants to older adults. World Allergy Organ J. 2020; 13(8):100449. PMID: 32817782.
5. Jiang N, Yin J, Wen L, Li H. Characteristics of anaphylaxis in 907 Chinese patients referred to a tertiary allergy center: a retrospective study of 1,952 episodes. Allergy Asthma Immunol Res. 2016; 8(4):353–361. PMID: 27126729.
6. Lee SY, Ahn K, Kim J, Jang GC, Min TK, Yang HJ, et al. A multicenter retrospective case study of anaphylaxis triggers by age in Korean children. Allergy Asthma Immunol Res. 2016; 8(6):535–540. PMID: 27582405.
7. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020; 13(10):100472. PMID: 33204386.
8. Shaker MS, Wallace DV, Golden DB, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020; 145(4):1082–1123. PMID: 32001253.
9. Oriel RC, Wang J. How to manage food allergy in nursery or school. Curr Opin Allergy Clin Immunol. 2018; 18(3):258–264. PMID: 29561357.
10. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000; 30(8):1144–1150. PMID: 10931122.
11. Sicherer SH, Simons FE. Section on Allergy and Immunology. Epinephrine for first-aid management of anaphylaxis. Pediatrics. 2017; 139(3):e20164006. PMID: 28193791.
12. Dubus JC, Lê MS, Vitte J, Minodier P, Boutin A, Carsin A, et al. Use of epinephrine in emergency department depends on anaphylaxis severity in children. Eur J Pediatr. 2019; 178(1):69–75. PMID: 30269250.
13. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol. 2005; 115(3):575–583. PMID: 15753907.
14. Korea Ministry of Government Legislation. Enforcement decree of the Act on 119 Rescue and Emergency Medical Services: Article 11. Updated 2019. Accessed April 29, 2021. https://elaw.klri.re.kr/kor_service/lawView.do?hseq=46887&lang=ENG.
15. Korea Ministry of Government Legislation. Enforcement rule of the Emergency Medical Service Act: Article 33. Updated 2019. Accessed April 29, 2021. http://www.law.go.kr.
16. Baek HS, Park SS. The emergency medical services system of South Korea: the present and future of emergency medical technicians. Medico Leg Update. 2019; 19(2):688–692.
17. Han SY, Ji HK, Yoon SW, Lee CH. Legislation feasibility studies for expanding the business scope of paramedics: focused on high level task in importance, need and allowance. Korean J Emerg Med Serv. 2015; 19(3):117–138.
18. Fleming JT, Clark S, Camargo CA Jr, Rudders SA. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015; 3(1):57–62. PMID: 25577619.
19. Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017; 5(5):1169–1178. PMID: 28888247.
20. Park SW, Lee BK, Yun SW. Necessity of epinephrine in pre-hospital stage: in the early management of anaphylaxis following a bee sting. J Korean Soc Emerg Med. 2012; 23(5):578–583.
21. Choi JH, Jo YH, Choi ES. Prehospital care status and improvement plan of 119 emergency medical technician to anaphylaxis patients. Korean J Emerg Med Serv. 2016; 20(1):57–70.
22. Rea TD, Edwards C, Murray JA, Cloyd DJ, Eisenberg MS. Epinephrine use by emergency medical technicians for presumed anaphylaxis. Prehosp Emerg Care. 2004; 8(4):405–410. PMID: 15626002.
23. Campbell RL, Bellolio MF, Knutson BD, Bellamkonda VR, Fedko MG, Nestler DM, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015; 3(1):76–80. PMID: 25577622.
24. Levis JT, Ford JB, Kuo AM. Intracranial hemorrhage after prehospital administration of intramuscular epinephrine. J Emerg Med. 2011; 40(6):e107–e110. PMID: 18757151.
25. Wood JP, Traub SJ, Lipinski C. Safety of epinephrine for anaphylaxis in the emergency setting. World J Emerg Med. 2013; 4(4):245–251. PMID: 25215127.
26. Yang MS, Lee SH, Kim TW, Kwon JW, Lee SM, Kim SH, et al. Epidemiologic and clinical features of anaphylaxis in Korea. Ann Allergy Asthma Immunol. 2008; 100(1):31–36. PMID: 18254479.
27. Statistics Korea. Population density 2019–2020. Updated 2021. Accessed April 30, 2021. https://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1007.
28. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol. 2016; 137(4):1128–1137.e1. PMID: 26806049.
29. Jahnz-Rozyk K, Raciborski F, Śliwczyński AM, Kłak A, Pinkas J. Anaphylaxis in Poland: the epidemiology and direct costs. Postepy Dermatol Alergol. 2017; 34(6):573–579. PMID: 29422823.